Skip to main content

Tomorrow Investor

Draganfly Appoints Colonel (Ret’d) Kevin Leblond to Lead Canadian Defence and Security Initiatives

Draganfly Hires Colonel (Ret’d) Kevin Leblond for Defence Role | GlobeNewsWire

Former Royal Canadian Air Force senior leader brings 29 years of operational, NORAD, NATO and unmanned systems experience to Draganfly’s growing Canadian defence business Ottawa, ON, Sept. 09, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions and systems, today announced the appointment of Colonel (Ret’d) Kevin Leblond as Vice-President, Canadian Defence and Security, where he will lead the Company’s Canadian military initiatives.

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

Draganfly Inc. has announced the appointment of Colonel (Ret’d) Kevin Leblond as Vice-President of Canadian Defence and Security. With 29 years of experience from the Royal Canadian Air Force, Colonel Leblond is well-equipped to guide Draganfly’s defence initiatives.

  • Leadership Experience: Colonel Leblond has served in various capacities within NORAD and NATO.
  • Drone Innovations: Draganfly is recognized for its cutting-edge drone technology.
  • Strategic Growth: His expertise will enhance Draganfly’s contributions to Canadian defence.

Why it matters: This strategic appointment is poised to fortify Draganfly’s position in the competitive defence sector.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.